Consumer Discretionary · Services-Educational Services · NYSE · CIK 730464 · FYE Jun 30 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $126.30Day +5.06%Mkt cap $4.3BP/E (FY) 20.4×Off 52W high −7.1%Vol (1Y) 47.3%
Daily closing price, split-adjusted to the current basis; 0.4y shown of 97 bars on file. Sampled to 97 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest4.9% of sh out |
| Days to cover4.6d |
| 13F net flow (QoQ)+2.17% |
| Top-10 13F concentration57.0% |
| Next report (est.)2026-08-08 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| P/E (FY)20.4× |
| Sales (TTM)$1.91B |
| Earnings (TTM)$234.1M |
| ROE16.9% |
| Net margin13.3% |
| ROIC14.9% |
| Debt / equity0.39× |
| EPS growth 3Y−1.3% |
| Sales growth 3Y9.0% |
No return windows available for CVSA.
| Ann. volatility (1Y)47.3% |
| Ann. volatility (3Y)47.3% |
| Sharpe (1Y)1.55 |
| Sharpe (3Y)1.55 |
| Max drawdown (1Y)−17.3% |
| Max drawdown (3Y)−17.3% |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BlackRock, Inc. | 5.2M | $603M | 15.37% | −3.0% |
| FMR LLC | 2.7M | $306M | 7.80% | +91.1% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.4M | $279M | 7.12% | new |
| ARIEL INVESTMENTS, LLC | 1.9M | $223M | 5.68% | +1.8% |
| DIMENSIONAL FUND ADVISORS LP | 1.8M | $204M | 5.21% | +0.4% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.5M | $172M | 4.38% | new |
| STATE STREET CORP | 1.3M | $156M | 3.97% | −1.6% |
| Capital World Investors | 1.0M | $119M | 3.02% | +15.8% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. Institutional 13F holdings sum to 100.8% of shares outstanding. Readings above 100% reflect securities-lending double counting: shares on loan to short sellers are reported long by both the lending institution and the one that bought them. FINRA short interest of 1,599,610 shares (settlement 2026-04-30) accounts for the excess.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | $1.20 | −24.5% | $487.0M | +4.5% |
| 2025-12-31 | 2026-01-28 | $2.11 | +6.6% | $503.4M | +12.4% |
| 2025-09-30 | 2025-10-30 | $1.67 | +41.5% | $462.3M | +10.8% |
| 2025-06-30 | 2025-08-07 | — | — | $457.1M | +11.5% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-08 is ESTIMATED from filing cadence (median gap 93d) — not company-confirmed.
Chamberlain University 41% · Walden University 39% · Medical And Veterinary 21%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
